Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Postbiotic Fermented Oat Gruel May Have a Beneficial Effect on the Colonic Mucosal Barrier in Patients With Irritable Bowel Syndrome

NCT05475314 is registered in ClinicalTrials.gov with Nordisk Rebalance A/S as lead sponsor.

NCT NCT05475314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Postbiotic Fermented Oat Gruel May Have a Beneficial Effect on the Colonic Mucosal Barrier in Patients With Irritable Bowel Syndrome
Lead sponsor
Nordisk Rebalance A/S
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
April 30, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome